CDR Tickets

Issue Number 4932
Summary [Summaries and DIS] Add ability to have footnotes
Created 2021-01-19 16:35:44
Issue Type Improvement
Submitted By Beckwith, Margaret (NIH/NCI) [E]
Assigned To Kline, Bob (NIH/NCI) [C]
Status Closed
Resolved 2021-02-25 14:22:14
Resolution Duplicate
Path /home/bkline/backups/jira/ocecdr/issue.282979
Description

We would like to be able to have footnotes in the DIS and the cancer information summaries. An example of how this would be used in in the DIS Pembrolizumab where certain indications link to the following note:  ¹This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that pembrolizumab provides a clinical benefit in these patients.

This is currently just being done using a superscript 1 and then adding the note at the end of the text. We would like to be able to have the number link to the note, and possibly have the note show if one hovers over the number. We need to be able to distinguish the number from superscripts and references numbers.

More discussion needed to flesh out requirements.

Elapsed: 0:00:00.002006